Whitehouse Laboratories Container Closure Integrity Testing Workshop Hosted By PDA Europe
(PRWEB) April 10, 2016 -- Whitehouse Laboratories is excited to announce that one of our experts in Container Closure Integrity Testing (CCIT) Justine Young, Associate Director of Container Qualification & CCIT, will be instructing a two-day training workshop hosted by Parenteral Drug Association (PDA) Europe alongside Lei Li, Ph.D., Senior Consultant Engineer of Eli Lilly and Company, in Venice, Italy on April 14th and 15th.
The workshop will concentrate on theoretical and practical fundamentals of various CCI testing technologies mentioned in the recently revised United States Pharmacopoeia General Chapter 1207 Package Integrity Evaluation – Sterile Products, enabling participants to implement CCI testing strategies in an effort to ensure adequate parenteral drug product protection. “This course will be an invaluable resource, assisting participants in navigating through current regulations and industry trends. I’m honored to be a part of it,” announced Ms. Young. Workshop participants will also receive hands-on experience of several test technologies such as mass extraction, electrical conductivity and capacitance, and laser-based headspace analysis.
The workshop will be one segment of the larger Parenteral Packaging Conference hosted by PDA Europe, which aims to promote understanding and discussion on current trends in pharmaceutical drug product packaging from advancements in glass, polymers, and elastomers to the design of primary and secondary packaging. Brandon Zurawlow, Associate Director of Container Qualification & CCIT, will join Ms. Young participating as an exhibitor at the Parenteral Packaging Conference and Exhibition held on April 12th and 13th.
“Over the past three years that Whitehouse Laboratories has participated in the Parenteral Packaging conference, there have been significant changes to guidance documents pertaining to CCIT. I am continuously impressed with PDA Europe’s dedication to educating industry and fostering important discussion on such topics” stated Mr. Zurawlow.
PDA Europe has supported numerous educational programs centered on pharmaceutical drug products and parenteral packaging, with package integrity being of heightened importance in recent years. This focus is reflected in the upcoming conference, which will include a session dedicated to container closure integrity test methods and approaches detailed in USP 1207. Application of the information presented will assist in the development of packages well-suited for product protection and aid regulatory compliance, resulting in a lowered risk of manufactured product integrity failures.
For more information about the PDA Europe Parenteral Packaging conference, please visit ww.pda.org.
About Whitehouse Laboratories
The leader in testing, Whitehouse Labs, a division of Albany Molecular Research Inc., offers comprehensive analytical services providing support for manufacturing from development to market. From analytical chemistry and material qualification to packaging optimization, Whitehouse Laboratories is the testing partner for the world's leading Pharmaceutical, Biotechnology, Medical Device, Life Sciences and Consumer Products organizations.
Mark Stier, Whitehouse Laboratories, http://www.Whitehouselabs.com, +1 (877) 837-8522, [email protected]
Share this article